Pediatric Dermatology.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Molecular Identification and Evaluation of Resistance to Antifungal Drugs inHealth science reports · 2026
   Article
2. Impact of Pediatric Dermatologic Conditions on Child and Parent Quality of Life.Cureus · 2023
   Article
3. Trichotillomania in Children and the Different Approaches between Dermatological and Behavioral Health Professionals at an Urban Tertiary Care Center.Skin appendage disorders · 2021
   Article
4. Skin Diseases in a Pediatric Hospital of Nepal.Dermatology research and practice · 2021
   Article
5. Pediatric dermatoses pattern at a Brazilian reference center.Jornal de pediatria
   Article
6. Efficacy and Safety of Topical Timolol for the Treatment of Facial Angiofibroma in Children with Tuberous Sclerosis Complex.Journal of research in pharmacy practice
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract